
Luminex Corporation LMNX
Country |
|
IPO year |
2000 |
Industry |
Medical instruments |
Stock Exchange |
NASDAQ GLOBAL |
Shares |
45.1 M |
Market Cap[1] |
$ 1.75 B |
EBITDA (LTM) |
$ 663 K |
P/E (LTM) |
- |
P/S (LTM) |
- |
EPS (LTM) |
- |
Other stocks of industry "Medical instruments"
| Issuer | Price | % 24h | Market Cap | Exchange | Country | |
|---|---|---|---|---|---|---|
|
Repro Med Systems
KRMD
|
$ 4.38 | -1.13 % | $ 202 M | Nasdaq Capital Market | ||
|
LeMaitre Vascular
LMAT
|
$ 109.67 | 1.68 % | $ 2.48 B | Nasdaq Global Market,SPB | ||
|
ICU Medical
ICUI
|
$ 130.31 | 0.29 % | $ 3.21 B | Nasdaq Global Select Market,SPB | ||
|
Akers Biosciences, Inc.
AKER
|
- | -9.52 % | $ 20.6 M | Nasdaq Capital Market | ||
|
Masimo Corporation
MASI
|
$ 178.7 | 0.14 % | $ 9.52 B | Nasdaq Global Select Market,SPB | ||
|
Atrion Corporation
ATRI
|
- | - | $ 810 M | Nasdaq Global Select Market,SPB | ||
|
Envista Holdings Corporation
NVST
|
$ 26.16 | 1.32 % | $ 4.39 B | NYSE | ||
|
Ekso Bionics Holdings
EKSO
|
$ 10.99 | 3.68 % | $ 26.7 M | Nasdaq Capital Market | ||
|
Merit Medical Systems
MMSI
|
$ 68.01 | -0.18 % | $ 4.02 B | Nasdaq Global Select Market,SPB | ||
|
Antares Pharma, Inc.
ATRS
|
- | - | $ 955 M | Nasdaq Capital Market | ||
|
Cantel Medical Corp.
CMD
|
- | -1.18 % | $ 3.4 B | NYSE | ||
|
CRH Medical Corporation
CRHM
|
- | - | $ 282 M | NYSE American | ||
|
Hill-Rom Holdings, Inc.
HRC
|
- | -0.05 % | $ 10.3 B | NYSE,SPB | ||
|
Varian Medical Systems, Inc.
VAR
|
- | -0.02 % | $ 16.3 B | NYSE | ||
|
Nephros
NEPH
|
$ 3.05 | -1.93 % | $ 31.7 M | Nasdaq Global Select Market | ||
|
Haemonetics Corporation
HAE
|
$ 57.5 | -1.66 % | $ 2.89 B | NYSE,SPB | ||
|
Baxter International
BAX
|
$ 16.67 | 0.27 % | $ 8.55 B | NYSE,SPB | ||
|
OraSure Technologies
OSUR
|
$ 3.11 | 0.81 % | $ 229 M | Nasdaq Global Select Market,SPB | ||
|
Isoray
ISR
|
- | 0.03 % | $ 108 M | NYSE American | ||
|
AngioDynamics
ANGO
|
$ 10.56 | -1.4 % | $ 431 M | Nasdaq Global Select Market | ||
|
Intuitive Surgical
ISRG
|
$ 471.81 | -1.3 % | $ 168 B | Nasdaq Global Select Market,SPB | ||
|
AtriCure
ATRC
|
$ 29.55 | -0.77 % | $ 1.41 B | Nasdaq Global Market,SPB | ||
|
Pro-Dex
PDEX
|
$ 49.96 | 4.2 % | $ 164 M | Nasdaq Global Select Market | ||
|
InfuSystem Holdings
INFU
|
$ 9.52 | -0.83 % | $ 197 M | NYSE American | ||
|
Pulse Biosciences
PLSE
|
$ 21.07 | 0.65 % | $ 1.42 B | Nasdaq Global Select Market | ||
|
iRhythm Technologies
IRTC
|
$ 119.44 | 1.1 % | $ 3.82 B | Nasdaq Global Select Market,SPB | ||
|
BioLife Solutions
BLFS
|
$ 19.8 | 3.29 % | $ 912 M | Nasdaq Global Select Market | ||
|
Milestone Scientific
MLSS
|
$ 0.29 | 0.7 % | $ 23.1 M | NYSE American | ||
|
Repligen Corporation
RGEN
|
$ 117.13 | 0.67 % | $ 6.53 M | Nasdaq Global Select Market,SPB | ||
|
electroCore
ECOR
|
$ 6.16 | 0.54 % | $ 52.3 K | Nasdaq Global Select Market | ||
|
The Cooper Companies
COO
|
$ 70.48 | 0.34 % | $ 14 B | NYSE,SPB | ||
|
STERIS plc
STE
|
$ 222.82 | 0.8 % | $ 22 B | NYSE,SPB | ||
|
Teleflex Incorporated
TFX
|
$ 106.43 | 0.43 % | $ 4.75 B | NYSE,SPB | ||
|
Predictive Oncology
POAI
|
- | - | $ 31.1 M | Nasdaq Capital Market | ||
|
Glaukos Corporation
GKOS
|
$ 106.87 | 0.04 % | $ 5.18 B | NYSE,SPB | ||
|
Utah Medical Products
UTMD
|
$ 64.65 | -0.74 % | $ 235 M | Nasdaq Global Select Market | ||
|
ResMed
RMD
|
$ 229.31 | 0.56 % | $ 33.5 B | NYSE,SPB | ||
|
Microbot Medical
MBOT
|
$ 2.55 | 0.99 % | $ 26 M | Nasdaq Global Select Market | ||
|
Retractable Technologies
RVP
|
$ 0.69 | -4.58 % | $ 20.7 M | NYSE American | ||
|
West Pharmaceutical Services
WST
|
$ 244.5 | 1.2 % | $ 17.7 B | NYSE,SPB | ||
|
DENTSPLY SIRONA
XRAY
|
$ 11.66 | 1.04 % | $ 2.33 B | Nasdaq Global Select Market,SPB | ||
|
NeuroMetrix
NURO
|
- | 5.05 % | $ 9.02 M | Nasdaq Global Select Market | ||
|
STAAR Surgical Company
STAA
|
$ 19.15 | 3.46 % | $ 949 M | Nasdaq Global Market,SPB | ||
|
Stereotaxis
STXS
|
$ 1.79 | -2.72 % | $ 163 M | NYSE American | ||
|
Becton, Dickinson and Company
BDX
|
$ 156.76 | 0.35 % | $ 45.1 B | NYSE,SPB | ||
|
Harvard Bioscience
HBIO
|
$ 5.21 | -2.43 % | $ 231 M | Nasdaq Global Market | ||
|
Alcon
ALC
|
$ 74.31 | 0.23 % | $ 40.4 B | NYSE |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.